Trial Management STREAM

31. Are Your Clinical Study Meetings Building Momentum, Or Wasting Time? 9/17/2025

    Transforming passive clinical trial meetings into active catalysts for success, aligning teams and accelerating timelines.

32. Strategic Considerations For A Successful CNS Clinical Development Pathway 2/7/2023

    Dr. Beatrice Setnik, Chief Scientific Officer at Altasciences, discusses tactics for a successful clinical development pathway for CNS-active drugs.

33. Audit Trails: Demonstrating TMF Oversight, Completeness, & Accuracy 5/4/2023

    Listen in as experts share their knowledge and experience to provide insights on leveraging audit trails for oversight, completeness, and accuracy of TMF management systems.

34. At The Crossroads Of Data: eCOA And Sensors Converging For Novel Insights 5/20/2025

    Leveraging sensors and eCOA addresses increasing clinical trial complexity and ensures a more efficient and effective study design.

35. Webinar: Reimbursement Methods For Sustainable CGT Business Models 10/10/2023

    Learn more about the key features of successful innovative pricing and reimbursement models as well as outcomes-based agreements and the ways to advance those strategies for cell and gene therapies.

36. What Is The Secret To Ongoing TMF Health? 8/22/2023

    Delve into specific tactics clinical teams can utilize for establishing immediate and long-lasting improvements to their TMF business processes.

37. The Real Payoff Of Reusable IRT/RTSM System Design 2/27/2026

    By utilizing consistent, repeatable system builds, sponsors gain significant advantages during protocol amendments and operational changes.

38. Ensuring Compliance In Gene Therapy Trials: IRB And IBC Views 9/23/2025

    Explore ethical and regulatory challenges in neurological gene therapy trials, with expert insights on IRB/IBC collaboration, consent protocols, and oversight for vulnerable populations.

39. Navigating Early Phase CNS-Active Drug Development 2/14/2023

    Early development of CNS-active drugs requires in-depth clinical expertise. Altasciences’ Dr. Beatrice Setnik, Chief Scientific Officer, examines the strategies to ensure early comprehensive data collection to fulfill regulatory requirements and aid in evaluating the risk/benefit profile.

40. Accelerating Clinical Trials Through Streamlined Confidential Disclosure Agreements 2/9/2026

    In this presentation, Dr. Christine Senn addresses the persistent challenge of study startup delays by focusing on a primary legal hurdle: the Confidential Disclosure Agreement (CDA).